Flu Vaccine Reduces Hospitalizations Due to Influenza Pneumonia
the ONA take:
Investigators at Vanderbilt University Medical Center found that more than 50% of hospitalizations due to influenza pneumonia could be prevented if the patient had received the influenza vaccine. Their study is published in the Journal of the American Medical Association.
The researchers used data from 2,767 patients age 6 months and older collected in the Etiology of Pneumonia in the Community (EPIC) study.
The patients were hospitalized with community-acquired pneumonia during the 2010, 2011, and 2012 influenza seasons, in Chicago, Memphis, Nashville, and Salt Lake City.
Approximately 6% of these inpatients had laboratory-confirmed influenza; the remaining inpatients tested free of influenza.
Among the influenza-free patients, 29% had a current flu vaccine, whereas only 17% of the influenza pneumonia patients had a current vaccination.
Older adults and patients with immunosuppressive conditions experienced lower benefit from the influenza vaccine in terms of preventing pneumonia hospitalization.
Therefore, higher flu vaccine doses have been recommended for these patients and have proven to be more effective than standard doses in older patients.
The effectiveness of higher-dose vaccines in patients with immunosuppressive conditions is currently being investigated.
More than 50% of hospitalizations due to influenza pneumonia could be prevented if the patient had received the influenza vaccine.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|